IRCCS Policlinico San Donato
San Donato Milanese, Milan, 20097, Italy
NCT Number: NCT04500964
Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR).
The purpouse of this study is to evaluate the indication to a second TAVR, the selection criteria of the second transcatheter aortic valve, procedural and clinical outcomes.
The primary endpoint of the study is overall mortality and Cardiovascular mortality at 1 year
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
San Donato Milanese, Milan, 20097, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Trancatheter aortic valve replacement
Time frame: 1 year
Overall mortality and Cardiovascular mortality at 1 year
Time frame: 1 year
Cerebrovascular events, bleeding complications, periprocedural MI, conduction disturbances, BVF, procedural success, device success, AKI (all according to VARC-2).
IRCCS Policlinico S. Donato
Other
Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve. An International Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.